Biotech


Piper Jaffray Weighs in as Trump Shakes up the Pharma Industry

After President-elect Donald Trump accused big pharma companies of “getting away with murder,” his inflammatory comments sent a shock wave through the market, …

Brexit: Biopharma Analysts Need to be Geopolitical Experts Too Now?

By Joshua E. Schimmer of Piper Jaffray With global markets being roiled by the apparently xenophobic and nationalistic fueled UK Brexit ‘Leave’ vote and …

AbbVie Inc (ABBV): A Favorable Risk/Reward Investment Opportunity

By Dirk S. Leach Today, long term investors are challenged in navigating the course and lining up that long drive for a investment …

Become a Better Biotech Investor by Following These 3 Steps

The world of biotech investing is exciting and volatile. People have seen their savings triple in value overnight, but also disappear just as …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts